Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer.
about
Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysisThe pivotal role of pathology in the management of lung cancerSystemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancerEZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.TP53 mutations in nonsmall cell lung cancerGlobal transcriptomic profiling using small volumes of whole blood: a cost-effective method for translational genomic biomarker identification in small animals.The prognostic role of the class III β-tubulin in non-small cell lung cancer (NSCLC) patients receiving the taxane/vinorebine-based chemotherapy: a meta-analysis.The role of gene expression profiling in early-stage non-small cell lung cancer.Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung CancerThe prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survivalExpressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions.Personalized medicine for lung cancer: new challenges for pathology.
P2860
Q21198839-9EA2D822-6335-4BB2-800B-B4E99884642DQ27010437-A11F2570-9CBC-4A54-B82C-E90EA45B7CF0Q34215504-DF4D32E3-9E31-48C2-BE74-E09BE87EEB8AQ34541488-F5D822DA-204D-47C8-B2A6-FA577B623CC6Q34559185-64AB229F-69EB-4FBE-934B-38C304C9CB0CQ35079266-219CB7CC-77E8-47A8-8ED7-855657052CD0Q35140489-48AAD5E7-A754-43E8-ABFC-41D3AD94F074Q35667675-FD325CCA-138F-4B83-B0B1-733224DBF6A6Q35771994-E6CEB6AE-9C9D-4328-A96F-6ED1F0ACDE02Q36558386-52313061-5B7E-41F7-B266-1AF0CD2FBDD0Q37225452-D7454CD3-196E-4968-B7B2-B00BD2EFDBB3Q37665660-F47CCBAF-88C7-43C5-B19F-D47678D10B0EQ37932029-573C4E17-86FE-4D13-9709-F478F86B3959
P2860
Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic and predictive mark ...... ge non-small cell lung cancer.
@en
Prognostic and predictive mark ...... ge non-small cell lung cancer.
@nl
type
label
Prognostic and predictive mark ...... ge non-small cell lung cancer.
@en
Prognostic and predictive mark ...... ge non-small cell lung cancer.
@nl
prefLabel
Prognostic and predictive mark ...... ge non-small cell lung cancer.
@en
Prognostic and predictive mark ...... ge non-small cell lung cancer.
@nl
P2093
P50
P1476
Prognostic and predictive mark ...... age non-small cell lung cancer
@en
P2093
Ana Belén Custodio
Aranzazu Manzano
Eugenio Cuadrado
Jana Bobokova
Rafael Alvarez
P304
P356
10.1097/JTO.0B013E3181A4B8FB
P577
2009-07-01T00:00:00Z